Learn how Paragraph IV certification under the Hatch-Waxman Act allows generic drugs to challenge patents and enter the market early, lowering costs for consumers.
Learn what generic drugs are, how bioequivalence works, and why they cost so much less than brand-name medications while remaining just as safe and effective.